The GOLD Podcast: Weekly Pharma Insights

This week, Tanja Dowe, CEO, Debiopharm Innovation Fund, discusses her passion for digital health tools. Drawing on her experience of investing in health technologies, she explores what it takes to be a successful entrepreneur, how these tools could improve life expectancies in cancer, and her highlights from a year of digital transformation for the pharmaceutical industry. 

This week, we take a look back at the standout moments in the pharmaceutical industry from October, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

We talk to Dr Emma Roffe, Oncology Country Head, Takeda UK, and Eric Low, Founder, Myeloma UK, about the challenge of combination treatments. The two discuss a pair of whitepapers recently produced by Takeda, which uncover why challenges exist, why for so long it has been classified as ‘too hard to solve’, as well as potential solutions that could revolutionise this area of healthcare. Disclaimer: This episode is editorially owned by EMG GOLD.

We talk to Massimiliano Siciliano, Digital Solution Director Europe, Novartis, about the potential of digital solutions for the pharmaceutical industry’s stakeholders and commercial teams, the technology he is most excited about within pharma’s digital revolution, and his three key principles for building high performing teams.

We talk to Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen. She shares her perspective on the industry’s drug pricing challenges and opportunities, details alternative pricing systems that could improve access in low-to-middle-income countries, and explores the shifting market access landscape within oncology.

This week, we look back at the highlights in pharma throughout September, covering the latest in COVID-19 developments, the most notable mergers and acquisitions, marketing standouts, and the latest in research and development news.

We talk to Matt Atkinson, Global Projects Director, Reuters Events Pharma, and Megan Reutin, Global Head of Omnichannel Analytics, Grünenthal Group, about the upcoming Reuters Pharma 2021 Event. We get a sneak peek into the event's line-up, consider the future of virtual events, and explore the rapid digital transformation that has taken place over the past year.

We talk to Julie Ross, President, Advanced Clinical, about gender parity in the workplace in aid of International Equal Pay Day. In the discussion, she covers her journey to leadership, the importance of determination and resilience, and why gender parity in healthcare and life sciences is so essential. 

We talk to Carol Lynch, Chief Business Officer, Sandoz, about how to increase the number of women in leadership positions in the pharmaceutical industry, the importance of mental health provisions in the workplace, and Sandoz's role in increasing access to biosimilars around the world.

We talk to Keren Leshem, Chief Executive Officer, OCON Healthcare about how she transformed OCON’s business strategy, the importance of educating women on their health and options, and how being mentored as well as acting as a mentor has shaped her career and outlook.

This week, we reflect on the highlights in pharma throughout August, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

This week, we speak with Dr Jerome Kim, Director General, International Vaccine Institute, about vaccines. The conversation covers the nuances of the vaccine development process, the pharmaceutical industry's role in addressing vaccine hesitancy and refusal, and equitable distribution. He also shares his experience of working within the US military.

This week, we talk to Dirk Kosche, President, Established Markets, Astellas Pharma Europe Ltd, about turning innovation into value for patients, the role of the pharmaceutical industry in addressing health inequities, and his appreciation for the Japanese work culture. 

This week, we reflect on the highlights in pharma throughout July, covering the latest in COVID-19 developments, the most prestigious mergers and acquisitions, marketing standouts, and the latest in research and development.

This week, we speak with Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy. She explores the idea of co-designing clinical trials and treatment with patients, discusses the concept behind reverse mentoring, and reveals how the rules of improvisation help her when leading teams.

This week, we speak with Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, about leadership, how the role of the medical sales representative has evolved, and what the ‘new normal’ will look like within pharma’s commercial teams.

This week, we reflect on the highlights in pharma throughout June, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.